Lung cancer patients must fight for life against cancer. It can be very difficult and it can be a long, difficult battle, but it is most definitely possible. As with all cancer patients, you will always have a better chance of survival the earlier the cancer is found and treated. Fast detection and treatment can help ensure recovery, while cancer found in the later stages can be very difficult to recover from.

Surgical treatment options, in order of complications, are wedge resection, lobectomy, and pneumonectomy. Wedge resection can be used to diagnose lung cancer or to remove a small tumor, while lobectomy is the removal of the lobe of the lung, to remove all of the cancer and tumor. Pneumonectomy is used as a last resort to get rid of cancer, but only in early stage, healthy patients. Pneumonectomy is the removal of the entire lung, so the complications are high, but it reduces your risk of reoccurring cancer significantly.

Other treatment options for lung cancer are chemotherapy and radiation therapy. They are often used in combination with one another. Chemotherapy is the use and combination of many different drugs to help kill cancer cells, while radiation therapy is the use of high-powered beams used to kill cancer cells.

In more severe cases of cancer you can consider target drug therapy, clinical trials, or supportive care. Target drug therapy is relatively new, and there are two different kinds. Tarceva target drug therapy stops the cancer cells from growing and dividing, while Bevacizumab kills the tumor by stopping its blood supply. Clinical trials are optional treatments by a variety of doctors. They are their latest theories for curing cancer. Clinical trials are never guaranteed, but being a part of them will assist the doctors in finding a true cure for lung cancer. Supportive care is used to help keep you comfortable. In supportive care you are no longer fighting the cancer, you are just relaxing and enjoying the rest of your life.

After treatment of lung cancer one always has a better chance of survival. While sometimes it may not seem long (3 to 5 years), it is better than the 4 to 5 months you would have had without the surgery. After treatment your life will change drastically. It is best if you develop a great support system within your family, and it also is a good idea to join cancer or lung cancer support groups. You can share your story, plus listen to others.

Kidney cancer is a type of cancer that effects your kidneys, which are located behind your stomach, in your lower back just below your ribs. There are two common types of kidney cancer. One is the renal cell carcinoma and the other is the renal pelvis carcinoma. Most cancers that originate in the renal tubule are renal cell carcinoma and cell adenocarcinoma while those that originate from the renal pelvis are transitional cell carcinoma. Other less common types include squamous cell carcinoma, renal oncocytoma and mesoblastic nephroma.

One common symptom of kidney cancer is palpable mass in the abdomen, hematuria and hydronephrosis. The mass is first felt in the anterior lumbar region, between the margins of the ribs and then grows to the umbilicus and then up to the hypochondrium. Where the cases are extreme, the mass fills the entire belly. The location of the colon furnishes an important diagnostic mark of all types of kidney cancers.

Sometimes cancer in the kidney may be secondary, the result of metastasis. This is spreading from a primary cancer source elsewhere in the body to the kidney. There are certain types of kidney cancer that have a known hereditary risk. Worldwide, North America leads in the number of people diagnosed with kidney cancer every year.

Fewer cases have been reported in Asia and Africa. In the United Kingdom, cancer of the kidney is the eighth most common cancer in men. In Europe, kidney cancer accounts for nearly 3% of all cancer cases. It is the fourteenth most common cancer in women worldwide. Wilms’ tumors are most kidney cancers reported in children followed by congenital mesoblastic nephroma. Surgery is a standard treatment for kidney cancer. It’s aim is to surgically remove the tumour, usually along with the kidney and lymph nodes containing the tumour, and, if possible, surgically remove single metastases if they occur.